Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2024

Aug 2, 2024

31041_dirs_2024-08-01_0af0786d-3286-4c0b-8d2c-8d33711cb32e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2024-07-30

Reporting Person: Backus William A. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-07-30 Common Stock M 3900 $84.09 Acquired 8888 Direct
2024-07-30 Common Stock S 3570 $179.247 Disposed 5318 Direct
2024-07-30 Common Stock S 330 $180.4656 Disposed 4988 Direct
2024-07-30 Common Stock S 904 $177.0955 Disposed 132 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-07-30 Stock Options (right to buy) $84.09 M 3900 Disposed 2029-02-13 Common Stock (3900) Direct

Footnotes

F1: Exercise of fully vested non-qualified stock options.

F2: This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

F3: This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.

F4: Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan.

F5: Reflects shares previously acquired under the Balchem Corporation 401(k) plan.

F6: Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.